Lova L. Sun, MD, MSCE

VLova Sun, Barbara Burtness, Yael Flamand, Laila A. Gharzai, Mei Tang, Nabil F. Saba EA3231: A randomized phase III study of BRAF-targeted therapy vs cabozantinib in RAI-refractory differentiated thyroid cancer with BRAF V600Em. , J Clin Oncol: 2026

Lova Sun, Max M. Wattenberg, Devora Delman, Kelly Markowitz, Jalal Jalaly, Devraj Basu, Robert Brody, Gregory S. Weinstein, Steven Cannady, James Gates, Karthik Rajasekaran, D Gregory Farwell, Ryan Carey, Ara Chalian, Christopher Rassekh, Aditi P. Singh, E. Paul Wileyto, Roger B. Cohen, Gregory L. Beatty A prospective trial of single-dose neoadjuvant PD-1 blockade with or without a CD40 agonist in HPV-negative HNSCC. , J Clin Oncol: 2026

Xavier Orcutt, Vivek Nimgaonkar, Lova Sun, Charu Aggarwal, Aaron B. Cohen, Ronac Mamtani, Qi Long, Ravi B. Parikh Machine learning risk stratification in a US-based database to identify subgroups of patients with PD-L1-high NSCLC who benefit from adding chemotherapy to pembrolizumab. , J Clin Oncol: 2026

Adam Barsouk, Jonathan H. Sussman, Maxim Yaskolko, Lova Sun, Aditi P. Singh, Charu Aggarwal, Roger B. Cohen, Melina E. Marmarelis, Corey J. Langer Performance status and tarlatamab outcomes in a large, multi-institution real-world database of 2L+ ES-SCLC. , J Clin Oncol: 2026

Rachel Jaber Chehayeb, Willdragon Wang, Lova Sun, Aditi P. Singh, Roger B. Cohen, Corey J. Langer, Charu Aggarwal, Melina E. Marmarelis Incidentally discovered lung cancer in explanted lungs at the time of lung transplantation: Management and outcomes. , J Clin Oncol: 2026

Xavier Orcutt, Vivek Nimgaonkar, Lova Sun, Charu Aggarwal, Aaron B. Cohen, Ronac Mamtani, Qi Long, Ravi B. Parikh Machine learning risk stratification in a US-based database to identify subgroups of patients with head and neck cancer who benefit from adding chemotherapy to pembrolizumab. , J Clin Oncol: 2026

Phurin Areesawangkit, Adam Barsouk, Maxim Yaskolko, Lucy Wang, Cole Friedes, Roger B. Cohen, Lova Sun, Charu Aggarwal, Melina E. Marmarelis, Aditi P. Singh, Kyle W. Robinson, Christopher D'Avella, Christine A. Ciunci, Steven J. Feigenberg, Jeffrey D. Bradley, Nikhil Yegya-Raman, Michelle Iocolano, Christiana Davis, Corey J. Langer Long-term survival outcomes of consolidative local ablative therapy after response to first-line systemic treatment in oligometastatic NSCLC. , J Clin Oncol: 2026

Millet YA, Spira AI, Baik CS, Hong MH, Shum E, Patel JD, Nguyen D, Janne PA, Piotrowska Z, Leighl NB, Matsumoto S, Sun L, Yang TY, Yoshida T, Nilsson MB, Heymach JV, Murray BW, Keats J, Lee S, Hsieh J, Zalutskaya A, Le X. BLU-451, a CNS-Active, Potent, and Selective Small-Molecule Inhibitor Against Uncommon EGFR Mutations , Mol Cancer Ther: 2026

Adam Barsouk, Maxim Yaskolko, Jonathan H. Sussman, Lova Sun, Roger B. Cohen, Charu Aggarwal, Corey J. Langer, Melina E. Marmarelis Sotorasib vs adagrasib in the 2L+ setting: Outcomes in a large, multi-institutional, real-world database of KRAS-G12C mutated mNSCLC , J Clin Oncol: 2026

Vikram Vasan, Lovely Raghav, Malay K. Sannigrahi, Robert Brody, Alexander Lin, John N. Lukens, Lova Sun, Iain M. Morgan, Ahmed Diab, Jalal Jalaly, Devraj Basu Biologic and clinical implications of HPV genome state variation in oropharyngeal cancers , J Clin Oncol: 2026